Fatigue in multiple sclerosis: a rational approach to evaluation and treatment (Q36060099)

11 August 2017

1 reference

title

Fatigue in multiple sclerosis: a rational approach to evaluation and treatment (English)

1 reference

11 August 2017

0 references

Jay H Rosenberg

1

1 reference

PubMed ID

15743552

11 August 2017

Renata Shafor

series ordinal

2

1 reference

11 August 2017

1 March 2005

1 reference

Current Neurology and Neuroscience Reports

11 August 2017

1 reference

11 August 2017

5

1 reference

11 August 2017

140-146

1 reference

11 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-005-0012-5

11 August 2017

0 references

cites work

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0012-5

Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0012-5

Multiple sclerosis and narcolepsy: possible similar genetic susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0012-5

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0012-5

'Fatigue' in patients with multiple sclerosis. Motor pathway conduction and event-related potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0012-5

Amantadine treatment of fatigue associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0012-5

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-005-0012-5

Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression

1 reference

12 December 2020

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

1 reference

12 December 2020

Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients

1 reference

12 December 2020

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

12 December 2020

The pineal gland, cataplexy, and multiple sclerosis

1 reference

12 December 2020

A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group

1 reference

12 December 2020

Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

1 reference

12 December 2020

Increased energy cost of walking in multiple sclerosis: effect of spasticity, ataxia, and weakness

1 reference

12 December 2020

The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele

1 reference

12 December 2020

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

1 reference

12 December 2020

Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis.

1 reference

12 December 2020

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

1 reference

12 December 2020

Sleep problems in multiple sclerosis.

1 reference

12 December 2020

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo

1 reference

12 December 2020

Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature

1 reference

12 December 2020

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group

1 reference

12 December 2020

Amantadine therapy for fatigue in multiple sclerosis

1 reference

12 December 2020

Sleep disturbance in chronic fatigue syndrome.

1 reference

12 December 2020

10.1007/S11910-005-0012-5

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15743552